The first clinical trial of an antiviral drug's effectiveness in people exposed to the deadly Ebola strain spreading in the Democratic Republic of Congo is underway, the WHO said Tuesday.
6 hours ago
0
2
When Ann O'Neill suffered a stillbirth in 2018, she was bewildered. She was already a mother to three healthy children and therefore had received no information on stillbirth prevention from her doctors. But when she brought ...
6 hours ago
0
1
Adolescents who use nicotine are more likely to report symptoms of anxiety, depression and other mental health problems than their peers who do not use nicotine. Girls appear to be particularly vulnerable, according to three ...
7 hours ago
0
2
Sudden unexpected postnatal collapse during the first week of life is rare but can have deleterious consequences. A new study from Karolinska Institutet shows that the condition is more common than previously estimated and ...
7 hours ago
0
1
Research involving a Rutgers professor sheds new light on the biological basis of schizophrenia by directly measuring synaptic connections in the human brain using specialized positron emission tomography (PET) imaging.
7 hours ago
0
3
The majority of Ebola virus cases in eastern Congo are from unknown chains of transmission, the World Health Organization's emergencies chief said on Tuesday and warned that the outbreak "continues to outpace the response ...
7 hours ago
0
1
Young adults who experienced alcohol-induced blackouts (AIBs) reported more alcohol-related consequences than they did when they drank similar amounts without blacking out, according to a new study. AIBs involve a period ...
7 hours ago
0
1
Researchers at Technion have uncovered a surprising natural mechanism through which the body repairs itself: Contrary to what was previously believed, mature, aged cells retain an extraordinary ability to "turn back time" ...
7 hours ago
0
1
Prostate cancer is one of the most common cancers affecting men worldwide. However, planning personalized radiotherapy in the advanced stages of the disease still requires more precise tools. Researchers at the Helmholtz-Zentrum ...
8 hours ago
0
1
A novel oral vaccine platform using genetically engineered Bifidobacterium could enhance anti-tumor immunity. In an exploratory Phase I clinical study, the vaccine was well tolerated and generated immunologic and clinical ...
8 hours ago
0
1
